10/14/2020 | CV | Market Commentary: Redfin on tap; Royal Caribbean volatile; Nova trades up; Allscripts skyrockets
|
12/20/2019 | CV | Allscripts greenshoe increases 0.875% convertibles to $218 million
|
12/6/2019 | CV | Market Commentary: Twitter convertible notes in focus following junk bond pricing; Caesars, Intel active
|
12/6/2019 | CV | Market Commentary: Morning Commentary: Twitter convertible notes in focus following junk bond pricing
|
12/5/2019 | CV | Market Commentary: Allscripts Healthcare convertible notes hit the market, trade tight; RH gains outright
|
12/5/2019 | CV | Market Commentary: Morning Commentary: Allscripts Healthcare convertible notes hit the market, trade tight
|
12/5/2019 | CV | New Issue: Allscripts prices $200 million seven-year convertibles to yield 0.875%, up 32.5%
|
12/4/2019 | CV | Market Commentary: Allscripts convertibles offering eyed; Chesapeake in focus; Liberty Media notes active
|
12/4/2019 | CV | Market Commentary: Morning Commentary: Allscripts convertibles offering on tap, viewed as 1.5 points cheap
|
12/3/2019 | CV | Market Commentary: Allscripts on tap; Cleveland-Cliffs contracts on acquisition news; Trip.com, Tesla active
|
12/3/2019 | CV | Allscripts talks $200 million seven-year convertible notes to yield 0.75%-1.25%, up 30%-35%
|
2/22/2019 | CV | Market Commentary: Wayfair, Allscript, Infinera, Zillow convertibles expand; Karyopharm Therapeutics tanks
|
11/2/2018 | CV | Market Commentary: Allscripts Healthcare convertibles contract; MercadoLibre notes expand; Boingo weakens
|
11/2/2018 | CV | Market Commentary: Morning Commentary: Allscripts Healthcare convertibles in focus, contract post-earnings
|
12/1/2015 | CV | Market Commentary: Planned Nuance convertibles slightly cheap; Teva deal timing accelerated; Inphi on tap
|
12/1/2015 | CV | Market Commentary: Morning Commentary: Planned Nuance slightly cheap; existing Nuance in line; Allscripts up with stock
|
11/12/2014 | CV | Market Commentary: New Isis Pharmaceuticals trades below par, slips on hedge; Dendreon steady; Home Inns adds
|
11/11/2014 | CV | Market Commentary: Existing Isis bonds, shares up; planned Isis looks slightly rich; Ascent Capital shares drop
|
11/7/2014 | CV | Market Commentary: Salix Pharmaceuticals slumps outright, adds on heavy deltas; Allcripts Healthcare drops
|
11/7/2014 | CV | Market Commentary: Morning Commentary: Salix slumps on earnings miss, lowered guidance; AllScripts Healthcare drops
|
7/10/2013 | CV | Market Commentary: Tesla steady at highs; Allscripts expands on hedge; Vantage Drilling, Merrimack on tap
|
6/18/2013 | CV | Allscripts greenshoe exercised, lifting convertibles to $345 million
|
6/13/2013 | CV | Market Commentary: Allscripts up on debut; new Take-Two trades under par; Halcon quiet after quick marketing
|
6/13/2013 | CV | New Issue: Allscripts Healthcare sells $300 million seven-year convertibles at 1.25%, up 30%
|
6/12/2013 | CV | Allscripts Healthcare to sell $300 million seven-year convertibles at 1%-1.5%, up 27.5%-32.5%
|
6/12/2013 | CV | Market Commentary: Workday trades around par on debut; Cornerstone better with shares; four deals on deck
|
4/29/2013 | BKCV | S&P trims Allscripts Healthcare rating
|
6/27/2012 | BKCV | S&P rates Allscripts loan BBB
|
5/25/2012 | BKCV | Moody's rates Allscripts loan Ba2
|
4/27/2012 | BKCV | S&P cuts Allscripts outlook
|
7/28/2011 | BKCV | S&P upgrades Allscripts
|
6/10/2009 | CV | Allscripts 3.5% debentures now convertible through end of quarter
|
10/10/2008 | CVSS | Allscripts sets special cash dividend amount at $5.23
|
2/14/2008 | CV | Market Commentary: Delta investors flee Allscripts, flock to Equinix; Molina, Amkor up; cost-cutting helps Advanced Medical Optics
|
11/16/2007 | CV | Defensive convertibles provide safety in a volatile market, Lehman Brothers report says
|
11/18/2005 | CVHY | Allscripts files $200 million shelf
|
6/30/2004 | CV | Allscripts Healthcare $75 million convertible yields 3.5%, up 40%
|
6/30/2004 | CV | Market Commentary: Market watches Fed; Allscripts, General Mills and Watson Pharmaceuticals trade
|
6/29/2004 | CV | Allscripts Healthcare $75 million convertible talked at 3%-3.5%, up 38%-42%
|